📰 Aadi Bioscience News
Page 4 - Aadi Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aadi Bioscience. Real-time updates on events, politics, business and more.
October 6, 2023
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Free Report) Chairman Neil Desai sold 25,569 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $4.37, for a total value of $111,736.53. Following the transaction, the chairman now directly owns 1,637,974 shares of the company’s stock, […]
October 6, 2023
Corporate Presentation October 2023 Forward-Looking Statements ...
October 5, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
October 3, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
October 3, 2023
  On Tuesday, 647 companies set new 52-week lows.
September 29, 2023
  Friday's session saw 112 companies set new 52-week lows.
September 20, 2023
Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The
September 20, 2023
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients...
September 20, 2023
LOS ANGELES, Sept. 20, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. , a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway...
September 18, 2023
/PRNewswire/ -- The "mTOR Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.coms offering. The global mTOR inhibitors market...